Belumosudil Versus Ruxolitinib for Steroid-Refractory or Breakthrough Hepatic cGVHD | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Belumosudil Versus Ruxolitinib for Steroid-Refractory or Breakthrough Hepatic cGVHD	Belumosudil; Hematopoietic Stem Cell Transplantation (HSCT); Hepatic cGVHD; Ruxolitinib; cGVHD	Recruiting	Not applicable	2026-08-31		NCT07794514

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
First Affiliated Hospital of Ningbo University	44
First Affiliated Hospital of Zhejiang University	201
Peking University People's Hospital	269
Ruijin Hospital	454
The First Affiliated Hospital of Zhengzhou University	203
Tongji Hospital	276
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	319

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Zhejiang University School of Medicine	Hangzhou	China	4